Effects of transplantation of hTIMP-1-expressing bone marrow mesenchymal stem cells on the extracellular matrix of degenerative intervertebral discs in an in vivo rabbit model

Spine

Volumn 39, Issue 11, 2014, Pages E669-E675

  Zhou, Yi ^a,b   Tu, Guanjun ^a   Cong, Lin ^a   Pei, Zifeng ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

BMSCs; Cell transplantation; Gene therapy; Intervertebral disc degeneration; TIMP

Indexed keywords

ADENOVIRUS VECTOR; HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE 1; PHOSPHATE BUFFERED SALINE; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL FREE SYSTEM; CELL ISOLATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEUS PULPOSUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTURE; QUANTITATIVE ANALYSIS; RABBIT MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

EID: 84926215879     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000316     Document Type: Article

References (31)

1. The Burden of Musculoskeletal Diseases in the United States. Chapter 2: Spine: low back and neck pain. Available at: www.boneandjointburden.org.2nd, 2011. Accessed May 14, 2012.
2. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine 2006;31:2151-61.
3. Shimer AL, Chadderdon RC, Gilbertson LG, et al. Gene therapy approaches for intervertebral disc degeneration. Spine 2004;29:2770-8.
4. Yoon ST. Molecular therapy of the intervertebral disc. Spine J 2005;5:S280-6.
5. Levicoff EA, Gilbertson LG, Kang JD. Gene therapy for disc repair. Spine J 2005;5:S287-96.
6. Salo J, Mackiewicz Z, Indahl A, et al. Plasmin-matrix metalloproteinase cascades in spinal response to an experimental disc lesion in pig. Spine 2008;33:839-44.
7. Karppinen J, Daavittila I, Solovieva S, et al. Genetic factors are associated with modic changes in endplates of lumbar vertebral bodies. Spine 2008;33:1236-41.
8. Rutges JP, Kummer JA, Oner FC, et al. Increased MMP-2 activity during intervertebral disc degeneration is correlated to MMP-14 levels. J Pathol 2008;214:523-30.
9. Sakai D. Future perspectives of cell-based therapy for intervertebral disc disease. Eur Spine J 2008, 17(suppl 4):452-8.
10. Colombini A, Lombardi G, et al. Pathophysiology of the human intervertebral disc. Int J Biochem Cell Biol 2008;40:837-42.
11. Risbud MV, Aibert TJ, Guttapalli A, et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine 2004;29:2627-32.
12. Richardson SM, Walker R V, Parker S, et al. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cell 2006;24:707-16.
13. Sakai D, Mochida J, Iwashina T, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 2005;30:2379-87.
14. Bosch P, Fouletier-Dilling C, Olmsted-Davis EA, et al. Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells. Mol Reprod Dev 2006;73:1393-403.
15. Zhou Yi, Tu Guan-Jun. Construction of recombinant adenovirus vector carrying the human tissue inhibitor of metalloproteinase 1 cDNA. J China Med Univ 2012;41:805-8.
16. Sobajima S, Kompel JF, Kim JS, et al. A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine 2005;30:15-24.
17. Masuda K, Aota Y, Muehleman C, et al. A novel rabbit model of mild, reproducible disc degeneration by an annulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine 2005;30:5-14.
18. Kim KS, Yoon ST, Li J, et al. Disc degeneration in the rabbit: a biochemical and radiological comparison between four disc injury models. Spine 2005;30:33-7.
19. Boxberger JI, Auerbach JD, Sen S, et al. An in vivo model of reduced nucleus pulposus glycosaminoglycan content in the rat lumbar intervertebral disc. Spine 2008;33:146-154.
20. Barbosa I, Garcia S, Barbier-Chassefiere V, et al. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 2003;13:647-53.
21. Thompson JP, Oegema TR, Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine 1991;16:253-60.
22. Nishida K, Kang JD, Gilbertson LG, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor β 1 encoding gene. Spine 1999;24:2419-25.
23. Yoon ST, Park JS, Kim KS, et al. LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004;29:2603-11.
24. Zhao Xin, Huang Shi, Zhang Hai-Long, et al. The effects of bone mesenchymal stem cell transferred by adenovirus vector-mediated hBMP-7 gene on proteoglycan of degenerative intervertebral disc of rabbits. Chin J Clin Anat 2008;26:413-5
25. Moon S, Nishida K, Gilbertson JG, et al. Biologic response of human intervertebral disc cell to gene therapy cocktail. Spine 2008;33:1850-5.
26. Paul R, Haydon RC, Cheng H, et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003;28:755-63.
27. Wallach CJ, Sobajima S, Watanabe Y, et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 2003;28:2331-7.
28. Steven K, Bernard P, Robert A, et al. Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J 2012;12:7-20.
29. Wei Jian-Wei, Wang De-Chun, Hu You-Gu. An in vitro study of nucleus pulposus cells of human degenerated lumbar intervertebral discs: the biological effects of tissue inhibitor of metalloproteinase 1-mediated by adeno-associated virus vector. Chin J Spine Spinal Cord 2008;18:680-3.
30. Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in a telocollagen to the degenerated intervertebral disc. Biomaterials 2006;27:335-45.
31. Sobajima S, Vadala G, Shimer A, et al. Feasibility of stem cell therapy for intervertebral disc degeneration. Spine J 2008;8:888-96